GSK may bid for Pfizer consumer unit, stoking dividend fears

LONDON (Reuters) - GlaxoSmithKline will look at acquisition options to bulk up its consumer health business as rivals like Pfizer and Merck KGaA quit the field, its chief executive said on Wednesday.